Isracann Biosciences are positioned nicely to capitalise on the weed industries future growth. Worth a read into. This is a buy IMO, confirmed by chart after breakout if you like technical analysis. Gap to fill for first target.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.